Showing results (81-90 of 293) with videos related to

Sort By:
Pageof 30
Cancer Research|June 18, 2003
Adenovirus with insertion-mutated E1A selectively propagates in liver cancer cells and destroys tumors in vivoTiejun Zhao, Xiao-Mei Rao, Xiaoming Xie, et al.
Advances in Experimental Medicine and Biology|October 3, 2015
Retinal Caveolin-1 Modulates Neuroprotective SignalingAlaina Reagan, Xiaowu Gu, Stefanie M Hauck, et al.
Cancer Biology & Therapy|November 20, 2008
Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesisChun Chui Tsao, Bin T Teh, Eric Jonasch, et al.
Human Pathology|November 3, 2010
TMPRSS2-ERG gene fusion in small cell carcinoma of the prostateCharles C Guo, Jane Y Dancer, Yan Wang, et al.
Cancer Discovery|July 2, 2013
Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancerChristopher J Logothetis, Gary E Gallick, Sankar N Maity, et al.
Hybridoma (2005)|April 19, 2012
Anti-caveolin-1 antibodies as anti-prostate cancer therapeuticsShu-Ru Kuo, Salahaldin A Tahir, Sanghee Park, et al.
Neurochemistry International|September 24, 2004
Loss of caveolin-1 expression is associated with disruption of muscarinic cholinergic activities in the urinary bladderH Henry Lai, Timothy B Boone, Guang Yang, et al.
Cancer Research|January 11, 2013
Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancerSalahaldin A Tahir, Guang Yang, Alexei Goltsov, et al.
Nature Reviews. Clinical Oncology|November 11, 2018
Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learnedLisa M Lowenstein, Spyridon P Basourakos, Michelle D Williams, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 1, 2007
Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapyYasutomo Nasu, Takashi Saika, Shin Ebara, et al.
Pageof 30